Explore the words cloud of the BaCTher project. It provides you a very rough idea of what is the project "BaCTher" about.
The following table provides information about the project.
ISTITUTO SUPERIORE DI SANITA
|Coordinator Country||Italy [IT]|
|Total cost||164˙203 €|
|EC max contribution||164˙203 € (100%)|
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
|Duration (year-month-day)||from 2015-11-01 to 2017-10-31|
Take a look of project's partnership.
|1||ISTITUTO SUPERIORE DI SANITA||IT (ROMA)||coordinator||164˙203.00|
|2||United States Department of Health and Human Services||US (Washington D.C.)||partner||0.00|
Cancer is the second cause of death in the western world and it is expected to become the leading one in developing countries in the next future. The long-term outcome of BaCTher is the improvement of the cancer treatment that can overcome the intrinsic limitations of the current therapies through the development of a new promising therapeutic strategy. The specific hypothesis behind the proposed research is that an attenuated Salmonella enterica serovar Typhimurium (STMΔznuABC) is able to influence the tumor microenvironment (TME) reprogramming or re-educating the immune response, and inducing a shift from protumorigenic inflammation to anticancer immunity, which results in a tumor growth control. This hypothesis is based on the observation that: 1) there is compelling scientific evidence of the effect of bacteria, and in particular Salmonella, against cancer growth; 2) STMΔznuABC is able to reduce cancer growth and to increase the average life expectancy in a mammary adenocarcinoma Balb/c mice model; 3) STMΔznuABC is able to penetrate and proliferate into the tumor cells inhibiting the proliferation of tumor cells at 24h post-treatment. Three specific aims are designed to: 1) investigate the relationship between STMΔznuABC and TME; 2) characterize the mechanism of STMΔznuABC antitumor activity; 3) validate the results obtained in the preliminary studies using alternative in vivo models. The Experienced Researcher (ER), from the Istituto Superiore di Sanità (ISS), Italy, will spend one year at the Cancer Immunobiology Section of the Cancer and Inflammation Program (CIP), Center for Cancer Research (CCR), division of the National Cancer Institute (NCI), Bethesda, MD USA, for mutual exchange of skills and know-how that will be transferred back to the beneficiary organisation (ISS), contributing to the establishment of a wider long-term collaboration between the ER and host institutions.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BACTHER" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "BACTHER" are provided by the European Opendata Portal: CORDIS opendata.
NGOs, Transnational Networks and the Transformation of Muslim Communities in CambodiaRead More
Neural mechanisms of crossmodal activity in blind and sighted individualsRead More
MULTI-level framework to enhance seismic RESilience of RC buildingsRead More